US OptionsDetailed Quotes
EAF240920P1500
- 0.60
- -0.10-14.29%
15min DelayClose Aug 28 16:00 ET
0.60High0.60Low
0.60Open0.70Pre Close2 Volume3 Open Interest1.50Strike Price120.00Turnover190.89%IV-5.63%PremiumSep 20, 2024Expiry Date0.65Intrinsic Value100Multiplier23DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8273Delta0.6423Gamma1.26Leverage Ratio-0.0021Theta-0.0006Rho-1.04Eff Leverage0.0005Vega
GrafTech Stock Discussion
Sign in to post a comment
GrafTech International Ltd.'s low P/S ratio is due to poor revenue performance and expected limited future growth. A significant change in fortune is needed for the P/S ratio to rise.
3
1
Increased forecast losses for GrafTech International hint at potential internal issues. Analysts' revenue downgrades and slower expected growth compared to the market may make investors wary.
Analysts are now more bearish on GrafTech International post results, downgrading revenue estimates with expectations of losses next year, ditching earlier profit forecasts. The tighter spread in price targets may indicate a solid view on its future, though concerns linger about its intrinsic value due to a weaker revenue and earnings outlook.
Although currently trading below the industry PE ratio, GrafTech International is expected to deliver negative earnings growth in the forthcoming years, introducing higher risk of future uncertainty. Potential investors should be aware of these risks while considering GrafTech International.
1
Gapping up
In reaction to earnings/guidance:
• $AutoZone (AZO.US)$ +2.7%, $Jacobs Engineering (J.US)$ +0.9% (reaffirms Q4 EPS and adjusted EBITDA guidance)
Other news:
• $Purple Innovation (PRPL.US)$ +32.6% (confirms it received an unsolicited, non-binding proposal from Coliseum Capital Management to acquire all of the outstanding capital stock of Purple for $4.35 per share)
• $KnowBe4 (KNBE.US)$ +24.9% (received a non-binding proposal f...
In reaction to earnings/guidance:
• $AutoZone (AZO.US)$ +2.7%, $Jacobs Engineering (J.US)$ +0.9% (reaffirms Q4 EPS and adjusted EBITDA guidance)
Other news:
• $Purple Innovation (PRPL.US)$ +32.6% (confirms it received an unsolicited, non-binding proposal from Coliseum Capital Management to acquire all of the outstanding capital stock of Purple for $4.35 per share)
• $KnowBe4 (KNBE.US)$ +24.9% (received a non-binding proposal f...
15
4
Gainers:
• $Akero Therapeutics (AKRO.US)$ +9.6% (announces two financing transactions with Pfizer (PFE) and Hercules Capital (HTGC) providing access to up to $125 million)
• $BrightSpire Capital (BRSP.US)$ +6.3% (increases dividend)
• $Humanigen (HGEN.US)$ +4% (entered into an agreement with PCI Pharma Services as part of preparations for commercialization in the United Kingdom)
• $Allison Transmission (ALSN.US)$ +2.8% (electric hybrid bu...
• $Akero Therapeutics (AKRO.US)$ +9.6% (announces two financing transactions with Pfizer (PFE) and Hercules Capital (HTGC) providing access to up to $125 million)
• $BrightSpire Capital (BRSP.US)$ +6.3% (increases dividend)
• $Humanigen (HGEN.US)$ +4% (entered into an agreement with PCI Pharma Services as part of preparations for commercialization in the United Kingdom)
• $Allison Transmission (ALSN.US)$ +2.8% (electric hybrid bu...
11
No comment yet
cong li : bought at 3.63 quit at 3.72 that's how lucky I was